Mod­er­na de­creas­es mR­NA pro­duc­tion with Lon­za in Switzer­land, brings some man­u­fac­tur­ing in-house

Mod­er­na is now de­creas­ing pro­duc­tion of mR­NA sub­stance at a Lon­za plant in Switzer­land as the mar­ket for Covid-19 vac­cines wanes and the com­pa­ny’s am­bi­tious plans to launch new prod­ucts and mR­NA med­i­cines out­side of Covid move for­ward.

In a Tues­day state­ment, Mod­er­na said do­ing so will “right-size” its man­u­fac­tur­ing strat­e­gy to be more in line with cur­rent vac­cine de­mands. It plans to large­ly han­dle man­u­fac­tur­ing on its own.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER